Advertisement

Topics

Zynerba’s Phase II epilepsy trial of ZYN002 fails to meet primary endpoint

19:00 EDT 8 Aug 2017 | Net Resources International

Zynerba Pharmaceuticals has reported top-line results from the Phase II STAR 1 clinical trial of ZYN002 to treat adult epilepsy patients with focal seizures.

Original Article: Zynerba’s Phase II epilepsy trial of ZYN002 fails to meet primary endpoint

NEXT ARTICLE

More From BioPortfolio on "Zynerba’s Phase II epilepsy trial of ZYN002 fails to meet primary endpoint"

Quick Search
Advertisement
 

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Epilepsy
Epilepsy is defined as a disorder of brain function characterized by recurrent seizures that have a sudden onset.  (Oxford Medical Dictionary).  A seizure is caused by a sudden burst of excess electrical activity in the brain, causing a tempora...